Tocilizumab-Aazg
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Tocilizumab-Aazg is used to treat juvenile arthritis, rheumatoid arthritis, cytokine release syndrome and giant cell arteritis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $3 million on Tocilizumab-Aazg across 1,563 claims for 444 beneficiaries.
Tocilizumab-Aazg is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $821.00 to $821.00 per ML. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$821.00 – $821.00
per ML
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Fresenius Kabi USA, LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Interleukin-6 Receptor Antagonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing TOCILIZUMAB-AAZG
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TYENNE 162 MG/0.9 ML AUTOINJCT | $820.9966 per ML | 0.00% |
TYENNE 162 MG/0.9 ML AUTOINJCT | $820.9966 per ML | 0.00% |
Frequently Asked Questions
What is Tocilizumab-Aazg used to treat?
Tocilizumab-Aazg is used to treat juvenile arthritis, rheumatoid arthritis, cytokine release syndrome and giant cell arteritis, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Tocilizumab-Aazg?
In 2024, Medicare Part D spent $3 million on Tocilizumab-Aazg across 1,563 claims for 444 beneficiaries.
How many Tocilizumab-Aazg products are on the market?
The Tocilizumab-Aazg drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Tocilizumab-Aazg?
NADAC reference prices for Tocilizumab-Aazg range from $820.9966 to $820.9966 per ML.
Which manufacturers make Tocilizumab-Aazg?
1 manufacturer lists Tocilizumab-Aazg in NADAC. Ranked by number of NDCs, the largest are Fresenius Kabi USA, LLC (2).
How has the price of Tocilizumab-Aazg changed recently?
Over the past 7 days, 0 Tocilizumab-Aazg NDCs rose and 0 fell, with a market-wide average change of +0.0%.